SCHEMBL1817268

SCHEMBL1817268

Cc1ccc(S(=O)(=O)N2CCOc3ccc(-c4cnc(C#N)nc4)cc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.53
▸ KMT2A Q03164 4/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ MAPT P10636 2/20 0.44
▸ PDE3B Q13370 4/20 0.44
▸ PDE3A Q14432 4/20 0.44
▸ CYP11B1 P15538 2/20 0.43
▸ CYP11B2 P19099 2/20 0.43
▸ PKM P14618 3/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ RIPK2 O43353 1/20 0.39
▸ NOD2 Q9HC29 1/20 0.39
▸ PKLR P30613 1/20 0.38
▸ TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1819619 0.89 CYP2C9 (0.52) CYP2C9KMT2AMEN1MAPTPDE3B
SCHEMBL1817249 0.86 PDE3B (0.41) CYP2C9KMT2AMEN1MAPTPDE3B
SCHEMBL1818601 0.85 CYP2C9 (0.57) CYP2C9KMT2AMEN1MAPTPDE3B
SCHEMBL12818485 0.85 PDE3B (0.39) CYP2C9KMT2AMEN1MAPTPDE3B
SCHEMBL12818373 0.84 SMN1; SMN2 (0.42) CYP2C9KMT2AMEN1MAPTPDE3B
SCHEMBL12818264 0.84 PDE3B (0.39) CYP2C9KMT2AMEN1MAPTPDE3B
SCHEMBL1817591 0.83 CYP2C9 (0.51) CYP2C9KMT2AMEN1MAPTPDE3B
SCHEMBL1819415 0.83 CYP2C9 (0.51) CYP2C9KMT2AMEN1MAPTPDE3B
SCHEMBL12818233 0.83 PDE3B (0.42) CYP2C9KMT2AMEN1MAPTPDE3B
SCHEMBL1816941 0.82 CYP2C9 (0.53) CYP2C9KMT2AMEN1MAPTPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback